Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy : are there molecular markers in the primary tumour that predict for 5-year clinical outcome ?

Nom du journal : Ann Oncol

Année : 2003

Volume : 14

Page de départ : 406

Page de fin : 413

Auteurs: Bonnefoi H, Diebold-Berger S, Therasse P, Hamilton A, van de Vijver M, MacGrogan G, Shepherd L, Amaral N, Duval C, Drijkoningen M, Larsimont D, Piccart M, Aleman BMP,